Related Experiment Video
Updated: Jun 26, 2026

Identification of Growth Inhibition Phenotypes Induced by Expression of Bacterial Type III Effectors in Yeast
Published on: March 30, 2010
Role of Pseudomonas aeruginosa type III effectors in disease
Joanne Engel1, Priya Balachandran
1Departments of Microbiology/Immunology and Medicine, Microbial Pathogenesis and Host Defense Program, Box 0654 UCSF, 513 Parnassus Ave, San Francisco, CA 94143, USA. jengel@medicine.ucsf.edu
Abstract:
Pseudomonas aeruginosa uses a type III secretion system (T3SS) to directly inject four known effectors into host cells. ExoU is a potent cytotoxin with phospholipase A2 activity that causes rapid necrotic death in many cell types. The biological function of ExoY, an adenylate cyclase, remains incompletely defined. ExoS and ExoT are closely related bifunctional proteins with N-terminal GTPase activating protein (GAP) activity toward Rho family proteins and C-terminal ADP ribosylase (ADPRT) activity toward distinct and non-overlapping set of targets. While almost no strain encodes or secretes all four effectors, the commonly found combinations of ExoU/ExoT or ExoS/ExoT provides redundant and failsafe mechanisms to cause mucosal barrier injury, inhibit many arms of the innate immune response, and prevent wound repair.
Related Concept Videos
Gene Regulation in Microbial Communities: Quorum Sensing
Regulation of Bacterial Virulence
Determinants of Bacterial Pathogenicity and Virulence
Gram-negative Bacterial Protein Secretion Systems
Colonisation of Pathogens
Plague

